Prices and Markets

Sareum Holdings – Potential strategy in COVID-19

The pandemic presents Sareum with an unexpected opportunity to test its lead TYK2 inhibitor, SDC-1801, in COVID-19. Such a move would require external funding, but this could accelerate clinical development timelines and catalyse a substantial increase in value for the company. Meanwhile, the recent £1m fundraising allows Sareum to advance SDC-1801 towards trials for mainstream autoimmune conditions... Read more Sareum intends to make grant applications to explore the activity of SDC-1801 in COVID-19, where the aim would be to reduce...

Ecofin Global Utilities and Infrastructure Trust – Resilient income

Investors in search of income have been hit hard by the COVID-19 crisis. Bond yields and interest rates have tumbled, and dividend cuts have proliferated. By contrast, the companies in Ecofin Global Utilities and Infrastructure Trust’s (EGL’s) portfolio have proved relatively resilient. In addition, when paying its dividend, EGL is able to use its distributable reserves to top up any shortfall in revenue that might occur... Read more The defensive attractions of the sector have been recognised and, as investors...

Page 10 of 51 1 9 10 11 51
-->